Supamas Sirisreetreerux
Overview
Explore the profile of Supamas Sirisreetreerux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Porntharukchareon T, Dechates B, Sirisreetreerux S, Therawit P, Tawinprai K
Front Endocrinol (Lausanne)
. 2024 Jul;
15:1337652.
PMID: 39022343
Introduction: Infection with SARS-CoV-2 virus may result in long COVID, a syndrome characterized by symptoms such as dyspnea, cardiac abnormalities, cognitive impairment, and fatigue. One potential explanation for these symptoms...
2.
Siripongboonsitti T, Tawinprai K, Porntharukcharoen T, Sirisreetreerux S, Thongchai T, Soonklang K, et al.
J Infect Public Health
. 2024 Jun;
17(7):102471.
PMID: 38865775
Background: Neutralizing monoclonal antibodies (NMabs) are recognized for their efficacy against non-severe COVID-19. However, spike protein mutations may confer resistance. This study evaluates the effectiveness of favipiravir (FPV) versus NMabs...
3.
Porntharukchareon T, Chartisathian W, Navinpipat M, Samdaengpan C, Cheirsilpa K, Lueprasitsakul A, et al.
Hum Vaccin Immunother
. 2023 Sep;
19(2):2251850.
PMID: 37671943
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increases mortality rates in older adults and those with comorbidities. Individuals with certain comorbidities may have a poor immune response and require early...
4.
Sirisreetreerux S, Porntharukchareon T, Dechates B, Rangsrisaeneepitak V, Therawit P, Worawitchawong S, et al.
Sci Rep
. 2023 Jul;
13(1):11798.
PMID: 37479776
The ChAdOx1 nCoV-19 vaccine (AZD1222) was used in Thailand during the early outbreak of coronavirus disease 2019 (COVID-19). A previous study showed a low immune response in diabetes patients after...
5.
Dechates B, Porntharukchareon T, Sirisreetreerux S, Therawit P, Worawitchawong S, Sornsamdang G, et al.
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992267
Background: Vaccines for SARS-CoV-2 have been critical for preventing disease. Previous research showed patients with diabetes have impaired immunity. This study aimed to determine the immunity to coronavirus after CoronaVac...
6.
Rangsrisaeneepitak V, Porntharukchareon T, Dechates B, Sirisreetreerux S, Tawinprai K
Diabetol Int
. 2022 May;
13(4):637-643.
PMID: 35528950
Patients with diabetes and coexistent coronavirus disease 2019 (COVID-19) have a higher risk of COVID-19 complications. Therefore, it is critical that sustained and effective immunogenicity against COVID-19 is achieved in...
7.
Sirisreetreerux S, Sujirakul T, Nimitphong H, Pinyopodjanard S, Saetung S, Chailurkit L, et al.
Sleep Breath
. 2020 Sep;
25(2):1069-1074.
PMID: 32951070
Purpose: Recent evidence suggests that diabetic retinopathy (DR) is associated with abnormal melatonin regulation, possibly related to dysfunction of the melanopsin-expressing intrinsically photosensitive retinal ganglion cells. This study explored melatonin...